In the original version of this article (1), the same image was inadvertently duplicated in Fig. 5J, column #2. These errors have been corrected in the latest online HTML and PDF versions of the article. The authors regret this error.
J, et al
Activation of MAPK signaling by CXCR7 leads to enzalutamide resistance in prostate cancer.
©2020 American Association for Cancer Research.
American Association for Cancer Research.